We use cookies to enhance your browsing experience and analyze site traffic. By continuing to use this site, you agree to our cookie policy. Privacy Policy
Stay updated on Click.mAb. news, technology progress, and industry insights
On June 11, 2026, the "AI-Driven Future: AI × Frontier Protein Technologies for Challenging Targets" summit co-hosted by Clickmab, Kactus Biosystems, and Sanyou Bio was successfully held in Shanghai, exploring new AI-driven antibody R&D paradigms and industry practices.
Read Full Article
On May 21-22, the "Antibody 3.0 | 2026 BioPlus Antibody Annual Conference" hosted by BioPlus Partners was successfully held in Suzhou. As a Gold Sponsor, Clickmab showcased its AI-driven antibody drug R&D platform and delivered a keynote in the oncology forum, exploring new trends, models, and opportunities in next-generation antibody R&D.
Read Full Article
Clickmab showcased its multi-agent AI antibody design platform Click.mAb. at CBA-China 2026, sharing the latest practices in de novo design, affinity maturation, humanization, and R&D collaboration.
Read Full Article
Led by Hualan Shares with follow-on investment from XtalPi and Xichuangtou, this round will accelerate Click.mAb. platform iteration and proprietary data flywheel building.
Read Full ArticleJikang Bio and BioAge reached a strategic preclinical collaboration on a novel APJ agonist antibody, with Clickmab's AI platform playing a key role in discovery and optimization.
Read Full ArticleClickmab's NAVIGATOR workflow for GPCR agonist antibody optimization won the Chinese Antibody Society Poster Presentation Award again.
Read Full ArticleClickmab is dedicated to empowering antibody discovery through generative AI and welcomes partners across the ecosystem.